Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study

SIMPLE SUMMARY: In the precision oncology era, liquid biopsy has dramatically revolutionized the management of such patients, potentially overcoming tissue biopsy limitations while entering the current clinical practice as a valuable diagnostic tool. However, despite the increasing implementation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gristina, Valerio, Barraco, Nadia, La Mantia, Maria, Castellana, Luisa, Insalaco, Lavinia, Bono, Marco, Perez, Alessandro, Sardo, Delia, Inguglia, Sara, Iacono, Federica, Cutaia, Sofia, Bazan Russo, Tancredi Didier, Francini, Edoardo, Incorvaia, Lorena, Badalamenti, Giuseppe, Russo, Antonio, Galvano, Antonio, Bazan, Viviana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735435/
https://www.ncbi.nlm.nih.gov/pubmed/36497493
http://dx.doi.org/10.3390/cancers14236013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735435/
https://www.ncbi.nlm.nih.gov/pubmed/36497493
http://dx.doi.org/10.3390/cancers14236013

Ejemplares similares